✦ LIBER ✦

P408 Safety of immunomodulators and anti-TNF drugs for the treatment of inflammatory bowel disease (IBD) during pregnancy

✍ Scribed by M.J. Casanova; M. Chaparro; E. Doménech; M. Barreiro-de Acosta; F. Bermejo; E. Iglesias; F. Gomollón; L. Rodrigo; X. Calvet; M. Esteve; E. García-Planella; S. García; C. Taxonera; M. Calvo; M. López; D. Ginard; M. Gómez; E. Garrido; J. Pérez-Calle; B. Beltrán; M. Piqueras; C. Saro; B. Botella; C. Dueñas; A. Ponferrada; M. Mañosa; M. Iglesias; A. Algaba; V. García-Sánchez; J. Maté; J.P. Gisbert

Book ID: 119636897
Publisher: Oxford University Press
Year: 2012
Tongue: English
Weight: 52 KB
Volume: 6
Category: Article
ISSN: 1873-9946
DOI: 10.1016/s1873-9946(12)60427-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of Immunomodulators and Anti-TNF

Safety of Immunomodulators and Anti-TNF Drugs for the Treatment of Inflammatory Bowel Disease (IBD) During Pregnancy

✍ Casanova, María José ;Chaparro, Maria ;Iglesias Flores, Eva ;Rodrigo, Luis ;Domè 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Sa1933 Safety of Immunomodulators and An

Sa1933 Safety of Immunomodulators and Anti-TNF Drugs for the Treatment of Inflammatory Bowel Disease (IBD) During Pregnancy

✍ Casanova, Maria José; Chaparro, Maria; Domenech, Eugeni; Acosta, Manuel Barreiro 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Safety of Thiopurines and Anti-TNF-α Dru

Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease

✍ Casanova, M J; Chaparro, M; Domènech, E; Barreiro-de Acosta, M; Bermejo, F; Igle 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 169 KB

Safety of immunomodulators and biologics

Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding

✍ Javier P. Gisbert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

The aim of this article is to critically review available data regarding the safety of immunomodulators and biological therapies during pregnancy and breast-feeding in women with inflammatory bowel disease. Methotrexate and thalidomide can cause congenital anomalies and are contraindicated during pr

Safety of Anti-TNF Agents During Pregnan

Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease

✍ Gisbert, Javier P; Chaparro, María 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 202 KB

P508 Drug survival and reasons for disco

P508 Drug survival and reasons for discontinuation of anti-TNF therapy in inflammatory bowel disease (IBD) in clinical practice

✍ Gisbert, J.P.; Arredondo, M.; Chaparro, M.; Cañamares, I.; Daudén, E.; Fernández 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 50 KB